Une candidature complète en une minute
Un CV et une lettre de motivation personnalisés, prêts à envoyer.
University of Oxford in Headington, Oxford welcomes a Postdoctoral Immunologist to join Professor Dame Sarah Gilbert's Outbreak Pathogens Vaccine Group. The role focuses on T- and B-cell responses to adenoviral-vectored and RNA vaccine antigens, supporting vaccine development towards clinical assessment.
Based in the IMS-Tetsuya Nakamura Building, you will perform in vivo immunogenicity studies, analyze data, adapt protocols, and contribute to reports and publications while mentoring junior team
Location: IMS-Tetsuya Nakamura Building, Old Road Campus, Roosevelt Dr, Headington, Oxford, OX3 7TY
We are seeking a highly motivated Postdoctoral Immunologist to join Professor Dame Sarah Gilbert's Outbreak Pathogens Vaccine Group at the University of Oxford. You will investigate T- and B-cell immune responses to adenoviral-vectored and RNA vaccine antigens, helping to advance novel vaccines against emerging and outbreak pathogens towards clinical development.
Working within the preclinical team, you will evaluate vaccine immunogenicity with in vivo models, analyse and present experimental data, adapt laboratory protocols and contribute to the development of new approaches. You will also collaborate with internal and external researchers, contribute to scientific discussions, reports and publications, and support the training and supervision of junior team members.
Reporting to Senior Preclinical Immunologist Barbara Dema Jimenez, you will be a highly organised and motivated researcher with experience in immunological assessment and a strong commitment to high-quality, safe laboratory practice. This is an exciting opportunity to contribute to a highly collaborative and translational vaccine research programme with a strong track record in developing vaccines against globally important pathogens.
This position is offered full time on a fixed term contract until 30 November 2028 and is funded by Calleva.
Only applications received before 12 midday on 12 November 2026 will be considered. Please quote 189191 on all correspondence.
Tagged as: Life Sciences